优化出院抗菌治疗:社区获得性肺炎或慢阻肺患者的转诊流程与电子评分系统评估
本研究评估在电子病历中启用包含ASP TOC电子变量的电子评分系统(ESS)后,对社区获得性肺炎(CAP)或慢阻肺(COPD)患者出院口服抗菌药物处方优化的影响。回顾性准实验显示,优化出院方案频率从69%提升至82%(P=0.033),药师完成的ASP TOC干预记录从4%增至25%(P<0.001)。ASP TOC干预、女性性别和COPD与优化出院方案独立相关。
要点
- 启用ASP TOC电子变量后,优化出院抗菌方案频率从69%升至82%。
- 药师完成的ASP TOC干预记录比例从4%显著增至25%。
- ASP TOC干预、女性和COPD是优化出院方案的独立相关因素。
核心结论
- 启用ASP TOC电子变量后,优化出院抗菌方案和药师完成的ASP TOC干预均增加。
- 药师通过ESS使用ASP TOC变量有助于改善出院处方。
研究设计与样本
- 经机构审查委员会批准的回顾性准实验,纳入因CAP或COPD急性加重(下呼吸道感染)出院并口服抗菌药物的患者。
- 主要终点为优化出院抗菌方案;采用多变量逻辑回归识别相关因素。
主要发现
- 优化出院方案频率从69%提升至82%(P=0.033)。
- 药师完成的ASP TOC干预记录从4%增至25%(P<0.001)。
- ASP TOC干预、女性性别和COPD与优化出院方案独立相关,调整比值比分别为6.57、1.61和3.89(95%CI分别为1.51-28.63、0.81-3.17和1.85-8.20)。
临床怎么用
- 可将ASP TOC电子变量整合入电子评分系统,用于优先安排药师工作量并促进出院抗菌方案优化。
局限性
- 回顾性准实验设计可能受未测量混杂因素影响。
- 样本量每组100例,研究时段和单中心设置可能限制外推性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Prescribing excess antibiotic duration at hospital discharge is common. A pharmacist-led Antimicrobial Stewardship Program Transition of Care (ASP TOC) intervention was associated with improved discharge prescribing. To improve the sustainability of this service, an electronic scoring system (ESS), which included the ASP TOC electronic variable, was implemented in the electronic medical record to prioritize pharmacist workload. The purpose of this study was to evaluate the implementation of the ASP TOC variable in the ESS in patients with community-acquired pneumonia (CAP) or chronic obstructive pulmonary disease (COPD). METHODS: This institutional review board-approved, retrospective quasi-experiment included patients discharged on oral antibiotics for CAP or COPD exacerbation (lower respiratory tract infection) from November 1, 2021, to March 1, 2022 (the preintervention period) and November 1, 2022, to March 1, 2023 (the postintervention period). The primary endpoint was optimized discharge antimicrobial regimen. A sample of at least 194 patients was required to achieve 80% power to detect a 20% difference in the frequency of optimized therapy. Multivariable logistic regression was used to identify factors associated with optimized regimens. RESULTS: Similar baseline characteristics were observed in both study groups (n = 100 for both groups). The frequency of optimized discharge regimens improved from 69% to 82% (P = 0.033). The percentage of ASP TOC interventions documented as completed by a pharmacist increased from 4% to 25% (P < 0.001). ASP TOC intervention, female gender, and COPD were independently associated with an optimized discharge regimen (adjusted odds ratios, 6.57, 1.61, and 3.89, respectively; 95% CI, 1.51-28.63, 0.81-3.17, and 1.85-8.20, respectively). CONCLUSION: After the launch of the ASP TOC variable, there was an increase in optimized discharge regimens and ASP TOC interventions completed. Pharmacists' use of the ASP TOC variable through an ESS can aid in improving discharge prescribing.
引用
- Belza-Mai AC, Efta J, Kenney R, et al. Optimizing discharge antimicrobial therapy: Evaluation of a transitions of care process and electronic scoring system for patients with community-acquired pneumonia or chronic obstructive pulmonary disease. Am J Health Syst Pharm. 2024. PMID: 38953520. doi:10.1093/ajhp/zxae174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。